資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

Medication Management Market by Systems (CPOE, CDSS, Automated Dispensing, Assurance Systems), Services (Medication Analytics, POC Verification, ADE Surveillance), Mode of Delivery (On-Premises, Web-Based, Cloud-Based) - Global Forecast to 2019

  • LinkedIn
  • facebook
  • Twitter
出 版 商:MarketsandMarkets
出版日期:2014/08/07
頁  數:298頁
文件格式:PDF
價  格:
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
線上訂購或諮詢
Medication errors and adverse drug events have been one of the major contributors to hospital readmissions globally. These issues add to the overall healthcare expenditure of the country. Medication management systems help in minimizing medication errors and adverse drug events by effective verification, recording, and reporting of medication administered to patient at every point of care. Medication management systems also enable automated inventory management for healthcare providers in both in-patient and out-patient healthcare environment.

The global medication management market is largely driven by the growing need to minimize medication errors in the healthcare systems, and government initiatives in both developed and developing economies to curtail soaring healthcare expenditures. Other benefits of medication management systems, such as automated inventory management are also contributing to the greater uptake of medication management solutions by healthcare providers across the globe.

In this report, the global medication management market is broadly segmented by systems, services, mode of delivery, and end users. The market, by software, is further segmented into computerized physician order entry, clinical decision support systems, administration software, inventory management software, automated dispensing systems, and assurance systems. On the other hand, the market, by services, is segmented into medication analytics, point-of-care verification, and ADE (adverse drug events) surveillance services offered by medication management solutions vendors. The end-users market is segmented into hospitals, pharmacy, and other healthcare institutions, while based on the mode-of-delivery; the market is divided into on-premises, web-based, and cloud-based deployment models.

The medication management market has experienced strong growth over the past few years, and is further expected to grow at an approximate CAGR of 14%–16% during the forecast period of 2014 to 2019. The overall growth of this market is mainly driven by the rise in the ageing population, and the incidence of chronic illnesses leading to greater risks of medication errors. The government initiatives to reduce healthcare costs and improve quality of healthcare delivery are also propelling the growth of this market.

The services segment currently dominates the medication management systems market, with the remaining share being occupied by the software market. Further, the services market is expected to grow at a strong CAGR during the forecast period, owing to an increasing demand for point-of-care verification and ADE surveillance services in the developed economies.

Geographically, the emerging markets in the Asia-Pacific (APAC) and the Middle Eastern regions are expected to show a high growth rate in the coming years. South Korea and Singapore are expected to be the most promising markets for medication management systems in the APAC region.

Some major players in this market are CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), and Omnicell, Inc. (U.S.). Emergence of smaller players operating at the regional levels has led to greater competitiveness in the medication management systems market over the years. Amidst the market growth and increasing competitiveness, many of the global players in the medication management systems market are trying to maintain their market share by developing new products and enhancing the existing ones, forming partnerships/alliances, and through acquisitions.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios offered by the top players in the medication management market. The report analyzes the medication management market by systems, services, end-users, and mode of delivery.
‧ Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the medication management market.
‧ Market Development: Comprehensive information about the lucrative emerging markets by product, functionality, and geography.
‧ Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the medication management market.
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the medication management market.
TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 REPORT DESCRIPTION 20
1.3 MARKETS COVERED 22
1.4 STAKEHOLDERS 24
1.5 RESEARCH METHODOLOGY 24
1.5.1 MARKET SIZE ESTIMATION 26
1.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 27
1.5.3 KEY DATA FROM SECONDARY SOURCES 29
1.5.4 KEY DATA FROM PRIMARY SOURCES 29
1.5.5 ASSUMPTIONS FOR THE STUDY 31
2 EXECUTIVE SUMMARY 33
3 PREMIUM INSIGHTS 37
3.1 GROWING DEMAND IN EMERGING MARKETS AIDING GROWTH OF THE GLOBAL MEDICATION MANAGEMENT SYSTEMS MARKET 37
3.2 GREATER UPTAKE OF CPOE AND MEDICATION ADMINISTRATION SYSTEMS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES 39
3.3 TECHNOLOGICAL ADVANCEMENTS DRIVING THE MARKET GROWTH 40
3.4 HEALTHCARE REFORMS TO AID PROMISING GROWTH IN THE MEDICATION MANAGEMENT SERVICES MARKET 41
4 MARKET OVERVIEW 43
4.1 INTRODUCTION 44
4.2 MARKET SEGMENTATION 45
4.3 MARKET DYNAMICS 47
4.3.1 MARKET DRIVERS 48
4.3.1.1 Technological Innovations Propelling the Market Growth 48
4.3.1.2 Provision for Medication Management Services under Healthcare Reforms Fueling Growth 48
4.3.1.3 Growth in Aging Population and High Incidences of Chronic Illness Accelerating Demand for Medication Management Systems 49
4.3.1.4 Healthcare Cost-reduction Measures to Support Growth of the Medication Management Systems Market 50
4.3.2 MARKET RESTRAINTS 51
4.3.2.1 Reluctance Among Healthcare Providers to Adopt Medication Management Systems Hinders Market Growth 51
4.3.2.2 High Implementation and Maintenance Expenses Restrain Market Growth 51
4.3.3 MARKET OPPORTUNITIES 52
4.3.3.1 Emerging Countries Offer Huge Potential For The Medication Management Market 52
4.3.3.2 Increasing Focus on Value-based Medicine Promoting Market Growth 52
4.3.4 MARKET TRENDS 53
4.3.4.1 Various Agreements and Acquisitions by Leading Vendors to Enhance Their Production Capabilities and Market Presence 53
4.4 GLOBAL MARKET SHARE ANALYSIS 54
5 GLOBAL MEDICATION MANAGEMENT SYSTEMS MARKET,
BY TYPE 58
5.1 INTRODUCTION 59
5.1.1 COMPUTERIZED PHYSICIAN ORDER ENTRY 60
5.1.2 CLINICAL DECISION SUPPORT SYSTEMS 63
5.1.3 ADMINISTRATION SOFTWARE 65
5.1.3.1 Electronic Medication Administration Record (eMAR) 68
5.1.3.2 Barcode Medication Administration (BCMA) 70
5.1.4 INVENTORY MANAGEMENT SYSTEMS 72
5.1.5 AUTOMATED DISPENSING SYSTEMS 74
5.1.5.1 Centralized Automated Dispensing Systems 76
5.1.5.1.1 Robots/Robotic Automated Dispensing Systems 78
5.1.5.1.2 Carousels 80
5.1.5.2 Decentralized Automated Dispensing Systems 82
5.1.5.2.1 Pharmacy-based Automated Dispensing Systems 85
5.1.5.2.2 Ward-based Automated Dispensing Systems 87
5.1.5.2.3 Automated Unit Dose Dispensing Systems 89
5.1.6 MEDICATION ASSURANCE SYSTEMS 91
6 GLOBAL MEDICATION MANAGEMENT SERVICES MARKET,
BY TYPE 93
6.1 INTRODUCTION 94
6.2 POINT-OF-CARE VERIFICATION 97
6.3 MEDICATION ANALYTICS 99
6.4 ADVERSE DRUG EFFECTS SURVEILLANCE 101
7 GLOBAL MEDICATION MANAGEMENT MARKET, BY MODE OF DELIVERY 103
7.1 INTRODUCTION 104
7.2 ON-PREMISE MODEL 106
7.3 WEB-BASED MODEL 108
7.4 CLOUD-BASED MODEL 109
8 GLOBAL MEDICATION MANAGEMENT MARKET, BY END USER 112
8.1 INTRODUCTION 113
8.2 HOSPITALS 114
8.3 PHARMACIES 116
8.4 OTHERS HEALTHCARE INSTITUTIONS 118
9 GLOBAL MEDICATION MANAGEMENT MARKET, BY GEOGRAPHY 120
9.1 INTRODUCTION 121
9.2 NORTH AMERICA 123
9.2.1 U.S. 128
9.2.2 CANADA 133
9.3 EUROPE 138
9.3.1 GERMANY 143
9.3.2 U.K. 147
9.3.3 FRANCE 151
9.3.4 ITALY 154
9.3.5 SPAIN 158
9.3.6 REST OF EUROPE (ROE) 162
9.4 ASIA-PACIFIC 166
9.4.1 JAPAN 171
9.4.2 CHINA 175
9.4.3 INDIA 179
9.4.4 REST OF ASIA-PACIFIC (ROAPAC) 183
9.5 REST OF THE WORLD (ROW) 189
9.5.1 MIDDLE EAST AND AFRICA 193
9.5.2 LATIN AMERICA 197
10 COMPETITIVE LANDSCAPE 202
10.1 INTRODUCTION 202
10.2 NEW PRODUCT LAUNCHES 205
10.3 MERGERS AND ACQUISITIONS 208
10.4 PARTNERSHIPS, COLLABORATIONS, AGREEMENTS, AND ALLIANCES 210
10.5 EXPANSIONS 213
10.6 OTHER DEVELOPMENTS 214
11 COMPANY PROFILES 217
(Overview, Financials, Products & Services, Strategy, & Developments)*

11.1 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 217
11.2 CAREFUSION CORPORATION 226
11.3 CERNER CORPORATION 238
11.4 GE HEALTHCARE 246
11.5 MCKESSON CORPORATION 253
11.6 MEDITECH 265
11.7 OMNICELL, INC. 268
11.8 OPTUM INC. 278
11.9 QUADRAMED CORPORATION 283
11.10 SIEMENS HEALTHCARE 286

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

APPENDIX 292
回上頁